SCGP has set an investment budget of Baht 13,000 million to expand business opportunities and enhance machinery, and strengthen the downstream consumer-related business. The Company is focusing on ASEAN domestic growth, where demand for packaging continues to rise in line with economic growth. SCGP will continue expanding in foodservice packaging, medical supplies and labware business—both of which have continuously high growth potential.
Wichan Jitpukdee, Chief Executive Officer, SCG Packaging Public Company Limited or SCGP, provided an update on the company’s business outlook during the SET Opportunity Day event, organized by the Stock Exchange of Thailand on March 4, 2025. He said that for this year, SCGP has allocated an investment budget of Baht 13,000 million, with Baht 8,000-10,000 million designated for merger and partnership (M&P), as well as production capacity expansion. The company will focus on investing in the expanding of downstream consumer-related business and growth in the ASEAN region while strengthen chain integration and access new growth markets. SCGP plans to execute one to two M&P deals this year and has set aside Baht 3,000-5,000 million to enhance machinery efficiency, develop technology and innovation, and support ESG target.
SCGP is firmly dedicated to boosting profitability by continuously expanding its consumer packaging business while focusing on sales across key ASEAN domestic markets, such as Thailand, Vietnam, Indonesia, and the Philippines. These markets have demonstrated sustained growth in packaging demand (ASEAN Domestic Growth), driven by economic expansion and increasing of international trade. Over the past year, ASEAN’s GDP grew by more than 5%, while SCGP’s domestic sales volume in the region, particularly for packaging paper, paper and polymer packaging, increased by over 10%. In addition, SCGP is investing in high-growth segments such as foodservice packaging and medical supplies and labware. Following its investment in VEM Thailand Co., Ltd., a manufacturer of high-performance polymer injection molding parts, SCGP has leveraged its expertise in polymer packaging to develop further and enhance production processes. As a result, SCGP has successfully produced a wider range of high-quality medical supplies and labware that meet customer needs, such as containers & samplings and pipette tips.
SCGP has focused on enhancing production efficiency and supply chain excellence by integrating Artificial Intelligence (AI) and data analytics to improve energy management in manufacturing process and analyze key operational data. SCGP is also prioritizing innovation developments and solutions by improving production efficiency and packaging design to create differentiation, enhance customer experience, and enhance profitability. SCGP has set a target for revenue from innovation and solutions-based products to account for 37% of total revenue. It will also continue to achieve Environmental, Social and Governance (ESG) initiatives in line with circular economy principles, increase the carbon footprint of products, and boost the proportion of alternative fuel usage to 39% of total fuel consumption this year.